Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 1 | Cellular & Molecular Biology Letters

Fig. 1

From: CircNF1 modulates the progression and immune evasion of esophageal squamous cell carcinoma through dual regulation of PD-L1

Fig. 1

CircNF1 characteristics and expression in ESCC. A Heat map of differentially expressed circRNAs between the serum of PD and PR patients by human circular RNA Array (circRNAs top ten upregulated and downregulated). B Dot plot representing the positive PCR amplification droplets (blue) and negative droplets without amplification (grey) of circNF1 in patients with different anti-PD-L1 treatment response. C Differential abundance of circNF1 between primary ESCC tissues compared with paired normal esophagus tissues (n = 108). D Expression levels of circNF1 in serum from patients with ESCC (n = 114) and healthy donors (n = 101). E Schematic representation of the genomic locus and structure of circNF1. F Divergent and convergent primers were used to amplify circNF1 in cDNA and gDNA in KYSE150 cells. G Actinomycin D treatment was performed to assess the stability of circNF1 and NF1 in ESCC cells. H The relative expression of circNF1 and NF1 mRNA after Rnase R treatment. I qRT-PCR analysis of circNF1 in the nuclear/cytoplasmic fraction of ESCC cells. J Representative FISH images of circNF1 (red) in KYSE150 and TE1 cells. Blue, DAPI staining of nuclei. Scale bar: 10 μm. The data are presented as mean ± SD. **P < 0.01, ***P < 0.001

Back to article page